Results 91 to 100 of about 11,472 (199)

IgE‐Binding Bacterial Components Not Yet Documented in the Allergen Databases and Their Allergenic Mechanisms: An EAACI Position Paper

Allergy, EarlyView.
ABSTRACT Among bacteria that are associated with the development and/or exacerbation of allergic/atopic diseases, several have been described to produce IgE‐binding components. However, only one bacterial protein, Bac s 1, is currently listed in the official database of the World Health Organization/International Union of Immunological Societies (WHO ...
Uta Jappe, Marua Abu Risha, Ioana Agache, Claus Bachert, Barbara Bröker, Riccardo Castagnoli, Gabriele Gadermaier, Richard E. Goodman, Amir Guemari, Christiane Hilger, Alain Jacquet, Sabine Kespohl, Ludger Klimek, Annette Kuehn, Jonas Lidholm, Vera Mahler, Markus Ollert, Thomas A. Platts‐Mills, Monika Raulf, Peter Schmid‐Grendelmeier, Frieder Schmiedeke, Marianne van Hage, Joana Vitte, Josefina Zakzuk, Anna Pomés   +24 more
wiley   +1 more source

Prediction of pediatric peanut oral food challenge outcomes using machine learning

Journal of Allergy and Clinical Immunology: Global
Background: Clinical testing, including food-specific skin and serum IgE level tests, provides limited accuracy to predict food allergy. Confirmatory oral food challenges (OFCs) are often required, but the associated risks, cost, and logistic ...
Jonathan Gryak, PhD, Aleksandra Georgievska, BS, Justin Zhang, BS, Kayvan Najarian, PhD, Rajan Ravikumar, MD, Georgiana Sanders, MD MS, Charles F. Schuler, IV, MD   +6 more
doaj   +1 more source

Propofol and peanut allergy [PDF]

Anaesthesia, 2007
K, Gangineni, A E, Scase, J, Fearn
openaire   +2 more sources

IgE Sensitization Patterns of Mothers and Their Offspring in the First Five Years of Life The CHILD Study

Allergy, EarlyView.
The spectrum of allergic sensitization in mothers and their offspring was characterized at ages 1–5 years at an extract‐ and molecular level in a North American birth cohort. Fel d 1 was the primary sensitizer in mothers, followed by Phl p 1. Perennial allergen sensitization (Der f 1, Der p 1) was rare at age one but rose sharply by age five.
Mary Asumta Anyango Kodydek, Myrtha E. Reyna, Akash Kothari, Mikhail Monteiro, Jennifer A. Hoang, Kristen Ericka San Diego, Aimee Dubeau, Lisa Hung, Xiaojun Yin, Elinor Simons, Stuart E. Turvey, Piushkumar J. Mandhane, Padmaja Subbarao, Theo J. Moraes, Thomas Eiwegger   +14 more
wiley   +1 more source

Efficacy and Safety of Abatacept Versus Placebo During Peanut Oral Immunotherapy for Adults With Severe Peanut Allergy

Allergy, EarlyView.
In this Phase 2a trial, severely peanut‐allergic participants were randomized to abatacept versus placebo with peanut oral immunotherapy (OIT) for 24 weeks, followed by 12 weeks of OIT alone. No significant difference was observed for the primary efficacy outcome (the relative change from baseline in peanut‐specific/total IgE ratio at 24 weeks), but ...
Marie‐Lee Simard, Camille Braun, Éloise Antony, Émilie Roy, Marie‐Ève Gingras, François Graham, Anne Des Roches, Louis Paradis, Kathryn Samaan, Florence Gingras‐Lessard, Roxane Labrosse, Thomas Eiwegger, Philippe Bégin   +12 more
wiley   +1 more source

Safety and Clinical Outcomes of High‐ Versus Low‐Dose Oral Peanut Immunotherapy in Polish Children With Peanut Allergy

Acta Paediatrica, EarlyView.
ABSTRACT Aim To compare safety and clinical outcomes of two different oral immunotherapy (OIT) maintenance doses (150 mg vs. 300 mg) of peanut protein in children with peanut allergy. Methods This prospective study enrolled 44 children aged 4–17 years with confirmed peanut allergy.
Klementyna Łyżwa, Magdalena Chojnowska‐Wójtowicz, Wioletta Zagórska, Marek Kulus, Katarzyna Grzela   +4 more
wiley   +1 more source

AYA22A Aptamers Mitigate Peanut Allergenicity: Insights from Degranulation Assays and Modulating Immune Responses

Allergies
Food allergy, particularly peanut allergy (PA), is a growing health concern affecting millions globally. PA can lead to severe reactions, including fatal anaphylaxis.
Mohamad Ammar Ayass, Trivendra Tripathi, Natalya Griko, Ramya Ramankutty Nair, Tutku Okyay, Jin Zhang, Kevin Zhu, Kristen Melendez, Victor Pashkov, Lina Abi-Mosleh   +9 more
doaj   +1 more source

Expanding the Utility of Gold Nanocluster “Allergolds” to Peanut Allergen Ara h 2

Allergy, EarlyView.
Gage O. Leighton, Victor Martinez‐Macias, Emmanuel R. De Diavoukana, Adalia Wambolt, Xunyang Chen, Scott A. Gabel, Scott A. Smith, Sarita U. Patil, Geniece Hallett‐Tapley, Alexander C. Y. Foo, Geoffrey A. Mueller   +10 more
wiley   +1 more source

Diagnostic Performance of Recombinant Peanut Allergens in Children: sIgE Cut‐Offs and Anaphylaxis Risk

Acta Paediatrica, EarlyView.
Diagnostic performance of recombinant peanut allergens for anaphylaxis risk in children. (A) Study population and clinical group. (B) Component‐specific IgE cut‐offs and associated odds ratios. (C) Forest plot of odds ratios for anaphylaxis. (D) Clinical interpretation of component‐specific IgE cut‐offs. ABSTRACT Aim Component‐resolved diagnostics (CRD)
Lisa Gazzolari, Annamaria Porreca, Marianna D'Andrea, Claudia Sala, Maurizio Pizzoli, Franca Faraoni, Paola Di Filippo, Dorina Hoxha, Sabrina Di Pillo, Francesco Chiarelli, Marina Attanasi   +10 more
wiley   +1 more source

Biomarkers Predicting Sustained Unresponsiveness After Oral Immunotherapy in the OPIA Trial

Allergy, EarlyView.
Duan Ni, Gabriela Pinget, Brigitte Santner‐Nanan, Catherine L. Lai, Laurence Macia, Dianne E. Campbell, Peter Hsu, Ralph Nanan   +7 more
wiley   +1 more source